Third Harmonic Bio, Inc.
THRD
$3.40
-$0.175-4.90%
12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
---|---|---|---|---|---|
Revenue | -- | -- | -- | -- | -- |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | -- | -- | -- | -- | -- |
Cost of Revenue | -- | -- | -- | -- | -- |
Gross Profit | -- | -- | -- | -- | -- |
SG&A Expenses | 5.90M | 5.73M | 5.68M | 5.06M | 4.49M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 16.44M | 17.07M | 14.07M | 11.29M | 10.41M |
Operating Income | -16.44M | -17.07M | -14.07M | -11.29M | -10.41M |
Income Before Tax | -13.11M | -13.80M | -10.71M | -7.86M | -6.84M |
Income Tax Expenses | -- | -- | -- | -- | -- |
Earnings from Continuing Operations | -13.11M | -13.80M | -10.71M | -7.86M | -6.84M |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -13.11M | -13.80M | -10.71M | -7.86M | -6.84M |
EBIT | -16.44M | -17.07M | -14.07M | -11.29M | -10.41M |
EBITDA | -16.43M | -17.06M | -14.06M | -11.28M | -10.39M |
EPS Basic | -0.29 | -0.33 | -0.26 | -0.20 | -0.17 |
Normalized Basic EPS | -0.18 | -0.21 | -0.17 | -0.12 | -0.11 |
EPS Diluted | -0.29 | -0.33 | -0.26 | -0.20 | -0.17 |
Normalized Diluted EPS | -0.18 | -0.21 | -0.17 | -0.12 | -0.11 |
Average Basic Shares Outstanding | 44.83M | 41.32M | 40.56M | 39.44M | 39.88M |
Average Diluted Shares Outstanding | 44.83M | 41.32M | 40.56M | 39.44M | 39.88M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |